The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Incident Frailty: An Analysis of the Cardiovascular Health Study (CHS)

Affiliations

¹ Division of Nephrology-Hypertension, University of California San Diego, San Diego, CA. Electronic address: opotok@health.ucsd.edu.
² University of Washington, Seattle, WA.
³ Kidney Research Institute, Seattle, WA.
⁴ Department of Health Research and Policy, Stanford University, Stanford, CA.
⁵ Division of Nephrology-Hypertension, University of California San Diego, San Diego, CA; Veterans Affairs San Diego Healthcare System, San Diego, CA.
⁶ Kidney Health Research Collaborative, San Francisco Veterans Affairs Health Care System and University of California San Francisco, San Francisco, CA.

O Alison Potok et al. Am J Kidney Dis. 2020 Dec.

. 2020 Dec;76(6):896-898.

doi: 10.1053/j.ajkd.2020.05.018. Epub 2020 Jul 16.

¹ Division of Nephrology-Hypertension, University of California San Diego, San Diego, CA. Electronic address: opotok@health.ucsd.edu.
² University of Washington, Seattle, WA.
³ Kidney Research Institute, Seattle, WA.
⁴ Department of Health Research and Policy, Stanford University, Stanford, CA.
⁵ Division of Nephrology-Hypertension, University of California San Diego, San Diego, CA; Veterans Affairs San Diego Healthcare System, San Diego, CA.
⁶ Kidney Health Research Collaborative, San Francisco Veterans Affairs Health Care System and University of California San Francisco, San Francisco, CA.

No abstract available

Comment in

Differences Between Cystatin C- and Creatinine-Based Estimated GFR-Early Evidence of a Clinical Marker for Frailty.
McAdams-DeMarco M, Chu NM, Segev DL. McAdams-DeMarco M, et al. Am J Kidney Dis. 2020 Dec;76(6):752-753. doi: 10.1053/j.ajkd.2020.07.010. Epub 2020 Oct 7. Am J Kidney Dis. 2020. PMID: 33039174 Free PMC article. No abstract available.

1. Ferguson TW, Komenda P, Tangri N. Cystatin C as a biomarker for estimating glomerular filtration rate. Curr Opin Nephrol Hypertens. 2015;24(3):295–300. doi:10.1097/MNH.0000000000000115 - DOI - PubMed
1. Fried LP, Borhani NO, Enright P, et al. The cardiovascular health study: Design and rationale. Ann Epidemiol. 1991;1(3):263–276. doi:10.1016/1047-2797(91)90005-W - DOI - PubMed
1. Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20–29. doi:10.1056/NEJMoa1114248 - DOI - PMC - PubMed
1. Dalrymple LS, Katz R, Rifkin DE, et al. Kidney Function and Prevalent and Incident Frailty. Clin J Am Soc Nephrol CJASN. 2013;8(12):2091–2099. doi:10.2215/CJN.02870313 - DOI - PMC - PubMed
1. Hart A, Blackwell TL, Paudel ML, et al. Cystatin C and the Risk of Frailty and Mortality in Older Men. J Gerontol A Biol Sci Med Sci. 2017;72(7):965–970. doi:10.1093/gerona/glw223 - DOI - PMC - PubMed